SENSEI BIOTHERAPEUTICS INC shareholders Q3 2023

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 24 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

SENSEI BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Newtyn Management, LLC 1,800,000$1,350,1800.33%
Deuterium Capital Management, LLC 11,000$8,8000.02%
Duquesne Family Office 100,000$800.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 112,900$84,6860.00%
RAYMOND JAMES & ASSOCIATES 14,000$11,2000.00%
TWO SIGMA INVESTMENTS, LP 10,876$8,7010.00%
BANK OF AMERICA CORP /DE/ 90,774$72,6190.00%
WELLS FARGO & COMPANY/MN 132$1060.00%
NORTHERN TRUST CORP 26,049$20,8390.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 136,318$102,2740.00%
STATE STREET CORP 25,774$19,3330.00%
MILLENNIUM MANAGEMENT LLC 57,309$42,9870.00%
HARBOUR INVESTMENTS, INC. 3$20.00%
MORGAN STANLEY 219$1750.00%
BlackRock Inc. 35,225$28,1800.00%
TWO SIGMA ADVISERS, LP 19,400$15,5200.00%
Qube Research & Technologies Ltd 4$30.00%
Banque Cantonale Vaudoise 3,900$30.00%
Tower Research Capital LLC (TRC) 7,259$5,8070.00%
External links

This page lists SENSEI BIOTHERAPEUTICS INC's shareholders in Q3 2023. To view SENSEI BIOTHERAPEUTICS INC's shareholder history, click here.